The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2615-2620

  Sosenko, Jay M ^a   Skyler, Jay S ^a   Palmer, Jerry P ^b   Krischer, Jeffrey P ^c   Yu, Liping ^d   Mahon, Jeffrey ^e   Beam, Craig A ^c   Boulware, David C ^c   Rafkin, Lisa ^a   Schatz, Desmond ^f   Eisenbarth, George ^d  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF COLORADO DENVER   (United States)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULINOMA ASSOCIATED ANTIGEN 2 ANTIBODY; MIAA ANTIBODY; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ALGORITHM; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BODY MASS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK ASSESSMENT; SCORING SYSTEM;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; RISK FACTORS; YOUNG ADULT;

EID: 84885862936     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0425     Document Type: Article

References (30)

1. Kulmala P, Savola K, Petersen JS, et al.; The Childhood Diabetes in Finland Study Group. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. J Clin Invest 1998;101: 327-336
2. Ziegler A-G, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parentswith type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999;48: 460-468
3. Achenbach P, Warncke K, Reiter J, et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 2004;53: 384-392
4. Mrena S, Virtanen SM, Laippala P, et al.; Childhood Diabetes in Finland Study Group. Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 2006;29: 662-667
5. Orban T, Sosenko JM, Cuthbertson D, et al.; Diabetes Prevention Trial-Type 1 Study Group. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 2009;32: 2269-2274
6. Steck AK, Johnson K, Barriga KJ, et al. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: Diabetes Autoimmunity Study in the Young. Diabetes Care 2011;34: 1397-1399
7. Xu P, Beam CA, Cuthbertson D, Sosenko JM, Skyler JS, Krischer JP. DPT-1 Study Group. Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis. Diabetes Care 2012;35: 1975-1980
8. Yu L, Boulware DC, Beam CA, et al.; Type 1 Diabetes TrialNet Study Group. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 2012;35: 1213-1218
9. Verge CF, Gianani R, Kawasaki E, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45: 926-933
10. Vardi P, Crisa L, Jackson RA. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulindependent) diabetic patients. Diabetologia 1991;34: 93-102
11. Chase HP, Voss MA, Butler-Simon N, Hoops S, O'Brien D, Dobersen MJ. Diagnosis of pre-type I diabetes. J Pediatr 1987;111: 807-812
12. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med 1985; 313: 461-464
13. Ginsberg-Fellner F, Witt ME, Franklin BH, et al. Triad of markers for identifying children at high risk of developing insulin- dependent diabetes mellitus. JAMA 1985;254: 1469-1472
14. Sosenko JM, Palmer JP, Greenbaum CJ, et al.; Diabetes Prevention Trial-Type 1 Study Group. Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care 2007;30: 38-42
15. Sosenko JM, Krischer JP, Palmer JP, et al.; Diabetes Prevention Trial-Type 1 Study Group. A risk score for type 1 diabetes derived from autoantibody-positive participants in the Diabetes Prevention Trial- Type 1. Diabetes Care 2008;31: 528-533
16. Sosenko JM, Skyler JS, Mahon J, et al.; Type 1 Diabetes TrialNet and Diabetes Prevention Trial-Type 1 Study Groups. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011; 34: 1785-1787
17. Mahon JL, Sosenko JM, Rafkin-Mervis L, et al.; TrialNet Natural History Committee; Type 1 Diabetes TrialNet Study Group. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes 2009;10: 97-104
18. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007; 104: 17040-17045
19. Efron B, Gong G. A leisurely look at the bootstrap, the jackknife, and crossvalidation. Am Stat 1983;37: 36-48
20. Heagerty PJ, Lumley T, Pepe MS. Timedependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000;56: 337-344
21. O'Leary LA, Dorman JS, LaPorte RE, et al. Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies? Diabetes Res Clin Pract 1991; 14: 183-190
22. Pociot F, Rønningen KS, Bergholdt R, et al.; Danish Study Group of Diabetes in Childhood. Genetic susceptibility markers in Danish patients with type 1 (insulindependent) diabetesdevidence for polygenicity in man. Autoimmunity 1994;19: 169-178
23. Siljander HT, Simell S, Hekkala A, et al. Predictive characteristics of diabetesassociated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 2009; 58: 2835-2842
24. Bingley PJ, Gale EAM; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 2006;49: 881-890
25. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetesmellitus.N Engl J Med 2002;346: 1685-1691
26. Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care 2005;28: 1068-1076
27. Andersson C, Vaziri-Sani F, Delli A, et al.; BDD Study Group. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Pediatr Diabetes 2013;14: 97-105
28. Andersen ML, Vaziri-Sani F, Delli A, et al. Association between autoantibodies to the arginine variant of the zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes. Pediatr Diabetes 2012;13: 454-462
29. Sorensen JS, Vaziri-Sani F, Maziarz M, et al.; Danish Study Group for Childhood Diabetes. Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3-6 years. Diabetes Res Clin Pract 2012;96: 204-210
30. Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med 2012;2:a007641